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Objective: Proton therapy can result in clinically significant radiation dermatitis. In some clinical scenarios, such as
lung or breast cancer, the risk of severe radiation dermatitis may limit beam arrangement and prescription doses.
Patients undergoing proton therapy for prostate cancer commonly develop mild radiation dermatitis. Herein, we
report the outcomes of two prostate cancer patients whose radiation dermatitis appears to have been substantially
diminished by transparent film dressings (Beekley stickers).
Methods: This is a descriptive report of the skin toxicity observed in two patients undergoing proton therapy for
prostate cancer at a single institution in 2011. A phantom dosimetric study was performed to evaluate the impact
of a transparent film dressing on a beam’s spread out Bragg peak (SOBP).
Results: Two patients with low risk prostate cancer were treated with proton therapy to a total dose of 79.2Gy
(RBE) in 1.8 Gy (RBE) fractions using two opposed lateral beams daily. Both patients had small circular (2.5 cm
diameter) transparent adhesive markers placed on their skin to assist with daily alignment. Patient 1 had markers in
place bilaterally for the entirety of treatment. Patient 2 had a marker in place for three weeks on one side and six
weeks on the other. Over the course of therapy, both men developed typical Grade 1 radiation dermatitis
(asymptomatic erythema) on their hips; however, in both patients, the erythema was substantially decreased
beneath the markers. Patient 2 demonstrated less attenuation and thus greater erythema in the skin covered for
three weeks compared to the skin covered for six weeks. The difference in skin changes between the covered and
uncovered skin persisted for at least 1 month. A phantom study of double scattered beam SOBP with and without
the marker in the beam path showed no gross dosimetric effect.
Conclusions: Transparent adhesive markers appear to have attenuated radiation dermatitis in these two patients
without affecting the SOBP. One patient may have exhibited a dose–response effect. The reproducibility and
underlying mechanisms are unclear. However, the potential to leverage this effect to improve proton-related
radiation dermatitis in other clinical scenarios is intriguing. Exploratory animal studies are underway.
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Proton therapy is an attractive radiation modality be-
cause plans can be created with relatively low integral
dose to normal tissues. However, radiation dermatitis is
common because of two features unique to proton
plans. First, unlike the large integral dose spread out
over a considerable surface area frequently seen with in-
tensity modulated radiation therapy with photons, the
physical properties of proton often permit the utilization* Correspondence: christojo@uphs.upenn.edu
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reproduction in any medium, provided the orof fewer beam angles. Second, due to the narrow Bragg
peak seen with a monoenergetic beam, proton plans
must utilize multiple energies in a given beam direction
to create a spread out Bragg peak (SOBP) to cover a tar-
get volume with uniform dose [1]. As Bragg peaks of dif-
ferent energies are summed to create uniform dose
across the target in depth, there is an increase in en-
trance dose compared with a monoenergetic Bragg peak
due to the summing of the entrance dose from each of
the individual peaks. Thus, the limited beam angles and
multiple energies utilized to create the SOBP withLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Diminished radiation dermatitis. Patient 1 demonstrated
substantially decreased erythema in the area of the skin beneath
the markers.
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In some clinical scenarios, such as lung or breast can-
cer, the risk of severe radiation dermatitis may limit pro-
ton beam arrangement options and total prescription
doses. In patients undergoing proton therapy for pros-
tate cancer, radiation dermatitis is a consistent finding
but is usually limited to asymptomatic erythema in the
treatment portal. Herein, we report the outcomes of two
prostate cancer patients whose radiation dermatitis
appears to have been substantially diminished by trans-
parent adhesive markers on the treated skin. In addition,
we advance several hypotheses to explain this apparent
protective effect.
Case presentations
This is a descriptive report of the skin toxicity observed
in two patients undergoing proton therapy for prostate
cancer at the University of Pennsylvania in 2011. Both
patients were consented and enrolled onto institutional
review board-approved prospective protocols as part of
their treatment. Skin toxicity was measured according to
the NCI Common Terminology Criteria for Adverse
Events v.4 (CTCAE) with asymptomatic, mild erythema
representative of grade 1 radiation dermatitis [2].
All patients undergoing proton or photon based radi-
ation therapy for prostate cancer at the University of
Pennsylvania have tattoos placed at the time of simula-
tion for daily localization purposes. In a small subset of
patients with difficult to identify tattoos, transparent ad-
hesive markers are placed at the time of set-up to aid in
daily setup. If these markers detach during a patient’s 9
week therapy, they may be replaced. Beekley transparent
markers are approximately 0.1 mm in thickness, 2.5 cm
in width, and are made of polyurethane film and acryl-
ate, a common semipermeable film. The film is imper-
meable to water and bacteria while allowing the
diffusion of air to the skin beneath. Neither the thickness
nor the composition is uniquely concerning for an inter-
action with a high energy proton beam.
Both patients in this series were treated for localized
low risk prostate cancer with definitive proton therapy.
Patient 1 was treated using a double scattering delivery,
and patient 2 was treated using uniform scanning deliv-
ery. Treatment included 44 fractions of 1.8 Gy (RBE) to
a total dose of 79.2Gy (RBE) using two opposed lateral
beams daily. After an initial 5040 CGE to the prostate
and proximal seminal vesicles, a boost of 2880 CGE was
given to the prostate only. Both patients were treated su-
pine in a knee/foot lock for immobilization. Nothing
was placed over the skin at the time of treatment. Skin
entrance doses ranged from 27 Gy to 29 Gy.
Patient 1 had the transparent adhesive marker placed
at the time of set-up. The marker was worn throughouttreatment and replaced every few weeks to ensure the
sticker remained in place. He developed typical asymp-
tomatic erythema on his hips bilaterally; however, the
erythema was substantially attenuated in the area of skin
beneath the markers (Figure 1). This attenuation was
seen and noted to be less pronounced throughout his
treatment. His radiation dermatitis was scored as Grade 1.
Per patient report, the difference between the erythema-
tous and non-erythematous skin (beneath the marker)
persisted for at least 4 weeks. The patient experienced no
other acute toxicity during treatment.
Patient 2 had the transparent adhesive marker placed
at the time of set-up. After 3 weeks, the marker on the
left hip detached and was not replaced. The marker on
the right hip remained in place for 6 weeks of treatment.
He also developed typical asymptomatic erythema on his
hips bilaterally. Similar to Patient 1, there was a decrease
in skin erythema beneath the adhesive markers. More-
over, the area of skin on the side that was covered for
only 3 out of the 6 weeks showed a less noticeable de-
crease in erythema compared to the surrounding uncov-
ered skin than the area that was covered for 6 weeks
(Figure 2). Difference between the erythematous and
non-erythematous skin (beneath the marker) persisted
approximately 3 months.
A gross dosimetric phantom study was performed to
assess the effect of transparent adhesive markers, in this
case Beekley stickers, on a beam’s SOBP. Using a PPC05
ion chamber in a water tank, two depth dose curves
were measured, one with and the other without the
transparent adhesive marker placed above the water,
centered over the ionization chamber. Double-scattered
Figure 2 Dose response effect. Patient 2 demonstrated more
erythema in the skin that was covered for only 3 weeks (Left Image)
compared to the skin covered for 6 weeks (Right Image), suggesting
a dose response effect.
Whaley et al. Radiation Oncology 2013, 8:19 Page 3 of 5
http://www.ro-journal.com/content/8/1/19beams with a 25 cm range and 10 cm modulation width
in a 10×10 cm2 field were used. These beams are com-
parable to the treatment fields of the patients considered
here which had an average range of 25.4 cm, modulation
width of 8.9 cm, and a field radius of 6 cm. The results
of the phantom dosimetric study are shown in Figure 3.
The plot demonstrates no substantial difference in the
SOBPs with or without the marker in place. Data points
were sampled every 2mm and have been normalized to
the dose in the center of the SOBP. The largest differ-
ence in magnitude between data points from the two
scans was 0.4% and the nominal range was identical (to
a hundredth of a centimeter) for both measurements.Figure 3 The double scattered SOBP demonstrated no apparent doseDiscussion
This observational series is the first, to our knowledge,
to report an apparent protective effect of transparent ad-
hesive markers on radiation dermatitis associated with
proton beam therapy. As an initial investigation step, we
performed basic dosimetric calculations on a phantom
water tank with adhesive markers that demonstrated no
measurable effect on the SOBP in phantom studies.
Whether this observation is reproducible and the under-
lying mechanisms by which it occurred are unclear;
however, this phenomenon has been observed in many
of our prostate cancer patients undergoing proton ther-
apy. We have used transparent film dressings in patients
receiving photon radiation in the past, but due to the
lower intrinsic skin dose and larger number of beam
angles, patients do not typically have any noticeable skin
erythema with treatment. Thus, it is similarly unclear
whether this effect is unique to skin effects of proton ra-
diation. Preclinical mechanistic and phenomenological
studies are currently underway using a porcine skin
model system to test a number of potential hypotheses.
These hypotheses separate roughly into two categories,
dosimetric and biological.
The possible dosimetric explanations for our observed
effect involve the transparent adhesive marker quantita-
tively altering the physical dose to skin tissue. One such
hypothesis is that the transparent adhesive marker dis-
rupts the charged particle equilibrium at the air-skin
interface [3]. Interface perturbations are known to occur
at air-tissue interfaces and certainly complicate proton
treatment planning for lung cancers. However, it is quitevariation with and without the transparent marker in the beam.
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position comprised mostly of hydrogen and carbon
would in any way change the typical air-skin interface.
Another hypothesis is that low energy particles are cre-
ated from scatter from the beam line components up-
stream of the patient. If the creation of low energy
scatter particles were occurring, there is a small possibil-
ity these particles could be diminished by 1 mm of sub-
stance. Additionally, if the skin reactions were related to
creation of low energy particles in the beam line compo-
nents, we would expect less skin dermatitis in the
patients who are treated on the fixed beam gantry that
does not have beam line components (i.e. scatterers,
MLC, or compensator). However, although we are cur-
rently evaluating this using a combination of measure-
ments and modeling, this also seems unlikely given the
phenomenon has also been observed with a fixed beam
proton gantry.
The possible biological explanations for our observed
effect involve transparent adhesive marker altering the
skin response to proton radiation. One hypothesis is that
the transparent adhesive marker is able to alter the diffu-
sion of oxygen from the external environment, leading
to decreased tissue oxygenation in the first few milli-
meters below the adhesive. The epidermis is known to
be devoid of blood vessels and relies on diffusion from
capillaries in the papillary dermis for oxygenation [4].
Additionally, it has been suggested that the outermost
0.25-0.4 mm of epidermis is almost entirely oxygenated
by external oxygen [5]. If this is in fact the case, small
manipulations could alter flow oxygen levels at the level
of the epidermis and deep dermis, leading to diminished
oxygenation. The mechanism of radiation dermatitis has
been documented to involve epidermal atrophy, upper
dermal edema, capillary dilation, and melanophage de-
position [6] and the slope of the dose response profile
for these effects would be decreased if the tissue experi-
enced a modest decrease in oxygen levels. Another hy-
pothesis is that the transparent adhesive marker may
alter the tensile forces on the most superficial portions
of the skin. As mentioned above, with limited blood sup-
ply to the epidermis, small manipulations could alter the
supply of inflammatory components from the general
circulation. The inflammatory response to radiation is
well-documented to involve an influx of inflammatory
components [7]. If the tension related to the markers
could alter the local response within the most superficial
millimeters beneath the markers, it seems reasonable
this could relate to the diminished response. Note that
these last two mechanisms could act simultaneously to
decrease tissue oxygenation. Finally, it is possible that
the adhesive could have radioprotective properties. This
could occur from direct antioxidant effects that have
been observed for topically applied oils and oil derivedsubstances or indirectly through stimulation of mild,
acute non-specific local inflammation that has been
demonstrated to provide radioprotection through un-
clear mechanisms [8].
Potential implications
There are several implications of our observations. First,
acute skin toxicity from proton beam has been shown to
be dose limiting; therefore, its reduction is an important
clinical goal. In a pilot study of proton therapy for acceler-
ated partial breast irradiation in 20 patients with limited
beam arrangements, investigators at the Massachusetts
General Hospital documented an unexpectedly high rate
of acute skin toxicity: moderate to severe skin color
changes developed in 79% of patients at 3 to 4 weeks and
moderate to severe moist desquamation in 22% of patients
at 6 to 8 weeks [9]. In an effort to reduce skin toxicity,
investigators at the MD Anderson have proposed an ap-
proach using 3–4 beams, though this comes at the
expense of exposing a greater volume of non-target tissue
[10]. Within our own department, among the patients
treated on prospective trials with proton therapy for lung,
sarcoma, and previously irradiated recurrent tumors, mild
to moderate (Grade II-III) radiation dermatitis is one of
the most common toxicities encountered. On occasion,
concern for radiation dermatitis has prompted treatment
breaks and alteration of beam arrangements.
The potential to leverage the apparent skin-sparing
effect described above to improve proton-related radi-
ation dermatitis in other clinical scenarios is intriguing.
Exploratory animal studies are underway.
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